Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.
J Biol Chem. 2012 Nov 2;287(45):38006-19. doi: 10.1074/jbc.M112.400580. Epub 2012 Sep 17.
Amyloid formation and accumulation is a hallmark of protein misfolding diseases and is associated with diverse pathologies including type II diabetes and Alzheimer's disease (AD). In vitro, amyloidogenesis is widely studied in conditions that do not simulate the crowded and viscous in vivo environment. A high volume fraction of most biological fluids is occupied by various macromolecules, a phenomenon known as macromolecular crowding. For some amyloid systems (e.g. α-synuclein) and under shaking condition, the excluded volume effect of macromolecular crowding favors aggregation, whereas increased viscosity reduces the kinetics of these reactions. Amyloidogenesis can also be catalyzed by hydrophobic-hydrophilic interfaces, represented by the air-water interface in vitro and diverse heterogeneous interfaces in vivo (e.g. membranes). In this study, we investigated the effects of two different crowding polymers (dextran and Ficoll) and two different experimental conditions (with and without shaking) on the fibrilization of amyloid-β peptide, a major player in AD pathogenesis. Specifically, we demonstrate that, during macromolecular crowding, viscosity dominates over the excluded volume effect only when the system is spatially non homogeneous (i.e. an air-water interface is present). We also show that the surfactant activity of the crowding agents can critically influence the outcome of macromolecular crowding and that the structure of the amyloid species formed may depend on the polymer used. This suggests that, in vivo, the outcome of amyloidogenesis may be affected by both macromolecular crowding and spatial heterogeneity (e.g. membrane turn-over). More generally, our work suggests that any factors causing changes in crowding may be susceptibility factors in AD.
淀粉样蛋白的形成和积累是蛋白质错误折叠疾病的一个标志,与包括 2 型糖尿病和阿尔茨海默病(AD)在内的多种病理学有关。在体外,淀粉样蛋白形成广泛地在不模拟体内拥挤和粘性环境的条件下进行研究。大多数生物体液的高体积分数被各种大分子占据,这种现象称为大分子拥挤。对于某些淀粉样蛋白系统(例如α-突触核蛋白)和在摇晃条件下,大分子拥挤的排除体积效应有利于聚集,而增加的粘度降低了这些反应的动力学。淀粉样蛋白形成也可以被疏水性-亲水性界面催化,体外以气-水界面和体内多种异质界面(例如膜)为代表。在这项研究中,我们研究了两种不同的拥挤聚合物(葡聚糖和菲可)和两种不同的实验条件(有和没有摇晃)对淀粉样β肽纤维形成的影响,淀粉样β肽是 AD 发病机制中的主要参与者。具体来说,我们证明在大分子拥挤时,只有当系统空间不均匀(即存在气-水界面)时,粘度才会超过排除体积效应。我们还表明,拥挤剂的表面活性剂活性可以严重影响大分子拥挤的结果,并且形成的淀粉样物种的结构可能取决于所使用的聚合物。这表明,在体内,淀粉样蛋白形成的结果可能受到大分子拥挤和空间异质性(例如膜周转)的影响。更一般地说,我们的工作表明,任何导致拥挤变化的因素都可能是 AD 的易感性因素。